Keyphrases
Non-valvular Atrial Fibrillation
100%
Warfarin
100%
Rivaroxaban
100%
Mitral Regurgitation
100%
Aortic Regurgitation
100%
Aortic Stenosis
100%
Native Valve
100%
Valve Disease
100%
Atrial Fibrillation
75%
Hazard Ratio
50%
Major Bleeding
25%
Safety Outcomes
25%
Rocket
25%
Efficacy Outcomes
25%
Intention-to-treat
12%
All-cause Mortality
12%
Confidence Interval
12%
Systemic Embolism
12%
Adjusted Hazard Ratio
12%
Potential Confounders
12%
Once-daily
12%
Prognostic Factors
12%
Heart Valve Prosthesis
12%
Antagonism
12%
Valve Prosthesis
12%
Oral Anticoagulants
12%
Stroke Prevention
12%
Relative Efficacy
12%
Valve Abnormality
12%
Vitamin K
12%
Cox Regression Analysis
12%
Mitral Stenosis
12%
Vascular Death
12%
Valvular Disease
12%
Factor Xa Inhibitors
12%
Embolism
12%
Direct Factors
12%
Medicine and Dentistry
Atrial Fibrillation
100%
Aortic Insufficiency
100%
Mitral Insufficiency
100%
Aortic Stenosis
100%
Valvular Heart Disease
100%
Warfarin
100%
Rivaroxaban
100%
Hazard Ratio
62%
Apoplexy
25%
Major Bleeding
25%
Intention-to-Treat Analysis
12%
Proportional Hazards Model
12%
Prognostic Factor
12%
Antithrombotic
12%
Mitral Valve Stenosis
12%
Prothrombinase
12%
Valve Prosthesis
12%
Diseases
12%
Oral
12%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
100%
Warfarin
100%
Rivaroxaban
100%
Mitral Valve Regurgitation
100%
Aortic Stenosis
100%
Valvular Heart Disease
100%
Aortic Regurgitation
100%
Bleeding
25%
Cerebrovascular Accident
25%
Anticoagulant Agent
12%
Vitamin K Group
12%
Blood Clotting Factor 10a
12%
Mitral Valve Stenosis
12%
Diseases
12%